GPS Maintenance Therapy in AML Remission

Trial
100%75%50%25%0%Jun 25Jun 26Jun 27Jun 28Jun 29Jun 30Jul 1Jul 2Jul 3Jul 4Jul 5Jul 6Jul 7Jun 25 • YES 0.1%Jun 29 • YES 0.0%Jun 30 • YES 0.0%Jul 1 • YES 68.3%Jul 2 • YES 83.1%Jul 3 • YES 6.1%Jul 4 • YES 6.1%Jul 5 • YES 6.1%Jul 6 • YES 0.0%Jul 7 • YES 81.5%
ResolvedYES
Oracle Evidence
Medical-journal style anatomical illustration of acute myeloid leukemia in bone marrow

Acute Myeloid Leukemia

Acute myeloid leukemia is a fast-moving blood cancer that starts in bone marrow. Overall survival matters because REGAL tests whether maintenance therapy helps patients live longer.

12026 US cases: 22,72025-year survival: 33.4%3Median age: 70